Coronary bypass surgery versus percutaneous coronary intervention: the saga continues
نویسندگان
چکیده
Coronary artery bypass graft surgery and percutaneous coronary intervention are the treatment options in patients with ischemia and multivessel coronary artery disease (CAD). Comparisons of coronary artery bypass graft and percutaneous coronary intervention have provided conflicting information. For years, experts have debated over the optimal treatment for patients with multivessel CAD. Current data indicate that clinical outcomes following invasive revascularization depend on patient characteristics, cardiac function, coronary disease distribution, and/or the number of diseased vessels. Lately, new data on treatment paradigms have enabled tailoring of treatment to fit the patient, with the anatomic SYNTAX score and some additional variables. This new data should be scrutinized to ensure its successful clinical utilization to provide individualized care for patients with CAD. In this article, we address some important coronary revascularization issues. We present and analyze the new information in the context of its clinical relevance, contemporary revascularization measures, and other tools designed to improve the care of patients with multivessel CAD.
منابع مشابه
Treatment decisions in stable coronary artery disease: insights from the Euro Heart Survey on Coronary Revascularization.
OBJECTIVE We sought to assess determinants of clinical decision making in patients with stable coronary artery disease. METHODS The 2936 patients with stable angina pectoris who enrolled in the Euro Heart Survey on Coronary Revascularization were the subject of this analysis. After the diagnosis has been confirmed, physicians decided on treatment: medical management or revascularization thera...
متن کاملEarly Metabolic Intervention in the Management of Coronary Artery Disease
The prevalence of ischemic coronary artery disease (CAD) continues to be on the increase globally, more so in India. Indian spectrum of disease seem to be different in terms of early onset as well as complexity in presentation. Therapeutic options include pharmacological therapy, percutaneous coronary interventions (PCI), Coronary artery bypass surgery (CABG), and newer modalities of treatment ...
متن کاملeComment: Costs of percutaneous coronary intervention versus coronary artery bypass surgery.
I read with great interest the recent report by Dr. Soran and coworkers regarding the current perspective of treating multivessel coronary disease w1x. Despite the fact that the authors brought into perspective a new way of analyzing the different groups that form the multivessel coronary artery disease, one point that struck me is the analysis of the cost-effectiveness of coronary artery bypas...
متن کاملDirect versus indirect thrombin inhibition in percutaneous coronary intervention.
Heparin has been used to prevent intravascular thrombosis and clotting on the surface of equipment used during percutaneous coronary interventions (PCI) since Andreas Gruentzig performed the first angioplasty. In fact, the development of coronary angioplasty and of coronary artery bypass surgery would probably not have been possible without heparin. However, with the availability of low molecul...
متن کاملPCI versus CABG in patients with complex coronary artery disease: Time for reconciliation?
INTRODUCTION Final 5-year results of the Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial were recently presented at the Transcatheter Cardiovascular Therapeutics (TCT) and European Society of Thoracic Surgery (ESTS) meetings [1]. SYNTAX is frequently quoted as “the most important percutaneous coronary intervention (PCI) vs. coronary artery bypass grafting (CABG) trial in multi...
متن کامل